Annual report for Checkpoint Trends Ltd. for FY-2023
26-05-2023
Checkpoint Trends Ltd - 531099 - Board Meeting Intimation for Notice Of Board Meeting
Checkpoint Trends Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2023 ,inter alia, to consider and approve 1. To adopt the Standalone Audited Financial Results of the Company for the quarter and year ended March 31, 2023. 2. To consider appointment of consultants for the purpose of reduction in capital subject to regulatory approval.17-05-2023
Checkpoint Trends Ltd - 531099 - Compliance Certificate Pursuant To Regulation 7(3) Of SEBI (LODR) Regulations, 2015 For The Year Ended March 31, 2023
Compliance Certificate Pursuant to Regulation 7(3) of SEBI (LODR) Regulations, 2015 for the year ended March 31, 202325-04-2023
Checkpoint Trends Ltd - 531099 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Checkpoint Trends Ltd 2 CIN NO. L74110MH1991PLC326598 3 Report filed for FY 2021-2022 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* 2020-21, 21-22 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) 0 8Quantum of (d), which has been met from (c)(e)* 0 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* 0 Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)2020-21, 21-22 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-Komal BehlDesignation :-Company Secretary Name of the Chief Financial Officer :- Abha Kapoor Designation : -CFO Date: 17/04/202317-04-2023
Checkpoint Trends Ltd - 531099 - Certificate Under Regulation 40(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended March 31, 2023
Certificate under Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the year ended March 31, 202312-04-2023
Checkpoint Trends Ltd - 531099 - Closure of Trading Window
Pursuant to the Company''s Securities Dealing Code, the Trading Window for dealing in the Company''s Equity Shares will remain closed from Saturday, April 1, 2023 for all Designated Employees of the Company. The closure is in connection with the declaration of Audited financial results of the Company for the quarter and year ending March 31, 2023. The Trading Window will open 48 hours after the said financial results are declared to the Stock Exchanges.30-03-2023
Checkpoint Trends Ltd - 531099 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of newspaper publication of Unaudited Financial Results for the quarter and Nine Month ended December 31, 202214-02-2023
Checkpoint Trends Ltd - 531099 - Board Meeting Outcome for Outcome Of Board Meeting
The Board of Directors of the Company at its meeting held on Monday, February 13, 2023, inter alia, has considered and approved the Unaudited Standalone Financial Results along with Limited review report for the quarter ended December 31, 202213-02-2023
RUBRA MEDICAMENTS LTD. - 531099 - Board Meeting Intimation for Notice Of Board Meeting
RUBRA MEDICAMENTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 ,inter alia, to consider and approve Standalone Unaudited Financial Results along with limited review report of the Company for the quarter ended December 31, 2022.31-01-2023
RUBRA MEDICAMENTS LTD. - 531099 - Closure of Trading Window
The Trading Window for dealing in the Company''s Equity Shares will remain closed from Sunday, January 1, 2023 for all Designated Employees of the Company. The closure is in connection with the declaration of unaudited financial results of the Company for the quarter ending December 31, 2022.28-12-2022